著者: OlayakiLuqman Aribidesi, OkesinaKazeem Bidemi, JesubowaleJesugbemi Daniel, AjibareAyodeji Johnson, OdetayoAdeyemi Fatai

原題: Orange Peel Extract and Physical Exercise Synergistically Ameliorate Type 2 Diabetes Mellitus-Induced Dysmetabolism by Upregulating GLUT4 Concentration in Male Wistar Rats.

著者: ChenY-H, ShihY-T, ChienC-S, TsaiC-S

原題: Predicting adverse drug effects: A heterogeneous graph convolution network with a multi-layer perceptron approach.

著者: ThikekarArchana K, ThomasAsha B, ChitlangeSohan S, BhalchimVrushali

原題: Effect of herbal formulation on glimepiride pharmacokinetics and pharmacodynamics in nicotinamide-streptozotocin-induced diabetic rats.

著者: SiddiquiRuqaiyyah, MungrooMohammad Ridwane, AnuarTengku Shahrul, AlharbiAhmad M, AlfahemiHasan, ElmoselhiAdel B, KhanNaveed Ahmed

原題: Antiamoebic Properties of Laboratory and Clinically Used Drugs against Naegleria fowleri and Balamuthia mandrillaris

著者: HalderMoumita, BhatiaYatin, SinghYashveer

原題: Self-assembled di- and tripeptide gels for the passive entrapment and pH-responsive, sustained release of an antidiabetic drug, glimepiride.

著者: LiHong-Chun, LuoKe-Xue, WangJie-Sheng, WangQin-Xian

原題: Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: A case report.

著者: ColagiuriStephen, MatthewsDavid, LeiterLawrence A, ChanSiew Pheng, SestiGiorgio, MarreMichel

原題: The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents.

著者: KalraSanjay, BahendekaSilver, SahayRakesh, GhoshSujoy, MdFariduddin, OrabiAbbas, RamaiyaKaushik, Al ShammariSameer, ShresthaDina, ShaikhKhalid, AbhayaratnaSachitha, ShresthaPradeep K, MahalingamAravinthan, AskhetaMazen, A RahimAly Ahmed, ElianaFatimah, ShresthaHari K, ChaudharySandeep, NgugiNancy, MbanyaJean Claude, AyeThan Than, LattTint Swe, AkanovZhanay A, SyedAbbas Raza, TandonNikhil, UnnikrishnanA G, MadhuS V, JawaAli, ChowdhurySubhankar, BajajSarita, DasAshok Kumar

原題: Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force.

著者: MajanovicSanja Klobucar, JanezAndrej, LefterovIvaylo, TasicSanja, CikacTatjana

原題: The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Balkan Region (Slovenia, Croatia, Serbia, Bulgaria): A Multicenter, Observational, Cross-Sectional Study.

著者: AhmedTarek A, El-SayKhalid M, AljaeidBader M, FahmyUsama A, Abd-AllahFathy I

原題: Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.

著者: DeaconC F, LebovitzH E

原題: Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.

著者: FlemingJoshua W, FlemingLaurie W, DavisCourtney S

原題: Fixed-dose combinations in type 2 diabetes - role of the canagliflozin metformin combination.

著者: KumarAjay

原題: Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.

著者: BarnettA H, PatelS, HarperR, ToorawaR, ThiemannS, von EynattenM, WoerleH-J

原題: Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension.

著者: YadavSarita Kumari, MishraShivani, MishraBrahmeshwar

原題: Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation.

著者: JermendyGyörgy

原題: [Incretin-based therapy for treating patients with type 2 diabetes].

著者: MathewAlex J, RajNixon N, SugappriyaM, PriyadarshiniSangeetha M

原題: Modeling of ATP-sensitive inward rectifier potassium channel 11 and inhibition mechanism of the natural ligand, ellagic acid, using molecular docking.

著者: ParkJeong-Kwon, KimSang-Pyo, SongDae-Kyu

原題: Ameliorating effects of sulfonylurea drugs on insulin resistance in Otsuka long-evans Tokushima Fatty rats.

著者: TawfikMona K, Abo-ElmattyDina M, AhmedAmal A M

原題: The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.

著者: DorkhanMozhgan, FridAnders

原題: A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.

著者: BlakeElizabeth W

原題: Pioglitazone hydrochloride/glimepiride.

著者: AttorreseGiuseppe, Massi-BenedettiMassimo

原題: Quality and behavior of glimepiride generics versus amaryl under stressed conditions.

著者: KimYoung Mi, YooSeung Hee, KangRae Young, KimMin Jung, BaeYoon Young, LeeYeon Kyung, JeonSu Jin, ChonKung Ju, ShinSang Mi, KimSang Geon, ParkKyoung Ho, SonIn Ja

原題: Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.

著者: GreenJennifer B, FeinglosMark N

原題: Are sulfonylureas passé?

著者: NauckM A, HompeschM, FilipczakR, LeT D T, ZdravkovicM, GumprechtJ,

原題: Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes.

著者: DerosaG, GaddiA V, PiccinniM N, SalvadeoS, CiccarelliL, FogariE, GhelfiM, FerrariI, CiceroA F G

原題: Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial.

著者: SuehiroTadashi, OsakiFumiaki, IkedaYukio, AriiKaoru, NakayamaFumi, OtaKikuko, HashimotoKozo

原題: Type 1 diabetes developed in a type 2 diabetic patient with severe insulin resistance.

著者: BellDavid S H

原題: Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.

著者: BellD S, MayoM S

原題: Improved glycemic control with use of oral hypoglycemic therapy with or without insulin.

著者: ReimannF, AshcroftF M, GribbleF M

原題: Structural basis for the interference between nicorandil and sulfonylurea action.

著者: Ivković-LazarT

原題: [News in oral therapy of diabetes mellitus].

著者: RiddleM

原題: Combining sulfonylureas and other oral agents.